Stay updated on Sorafenib Nivolumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Sorafenib Nivolumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sorafenib Nivolumab in Liver Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2, indicating an updated build of the page.
    Difference
    0.0%
    Check dated 2026-04-16T10:36:52.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    - Publications section was added, including a new PubMed reference: Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunction. These publications are automatically filled from PubMed.
    Difference
    0.4%
    Check dated 2026-03-18T17:21:25.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T18:05:10.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The funding-status notice about a lapse in government funding and the Revision: v3.4.1 notice were removed.
    Difference
    0.4%
    Check dated 2026-02-11T09:17:19.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Added a site-wide government funding/status notice and updated the page revision to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T04:57:08.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Show glossary has been added; the page now displays 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' metadata, while the previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' labels were removed.
    Difference
    0.2%
    Check dated 2026-01-28T03:24:16.000Z thumbnail image

Stay in the know with updates to Sorafenib Nivolumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sorafenib Nivolumab in Liver Cancer Clinical Trial page.